![Charles J. Democko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles J.
Democko currently works at Vigil Neuroscience, Inc., as Senior VP-Regulatory Affairs & Quality from 2024.
Mr. Democko also formerly worked at Connetics Corp., as Vice President-Regulatory Affairs, Humanigen, Inc., as Vice President-Regulatory Affairs & Quality from 2008 to 2014, Signature Therapeutics, Inc., as Vice President-Regulatory Affairs & Development, Novacea, Inc., as Vice President-Regulatory Affairs, CytomX Therapeutics, Inc., as Vice President-Regulatory Affairs & Quality, and Catalyst Biosciences, Inc., as Senior Vice President-Regulatory Affairs.
Mr. Democko received his undergraduate degree from The Ohio State University and Masters Business Admin degree from San Francisco State University.
| Sociétés | Poste | Début |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Conseiller Juridique Général | 01/09/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Conseiller Juridique Général | 03/02/2009 |
| CYTOMX THERAPEUTICS, INC. | Public Communications Contact | - |
| CATALYST BIOSCIENCES | Public Communications Contact | - |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Conseiller Juridique Général | - |
Signature Therapeutics, Inc.
 Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 9 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
